Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 731255Generated: October 30, 2026

Ethanol → HCID 137194576, compound

https://huagongshe.com/reaction/731255

Reaction equation

Participants

RoleNameHCIDCharge
ReactantEthanolHCID 702—
Reactant4-MethylmorpholineHCID 7972—
ReactantSodium ethoxideHCID 2723922—
Reactant1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
Reactant2H-1,2,4-Benzothiadiazine-3-acetic acid, 7-[(methylsulfonyl)amino]-, 1,1-dioxideHCID 24858539—
ReactantHCID 57671241HCID 57671241—
SolventAcetic AcidHCID 176—
SolventDimethylformamideHCID 6228—
ProductHCID 137194576HCID 13719457631.7%

Reaction Conditions

Temperature25 °C

Reaction Steps

A solution of (7-methanesulfonylamino-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-acetic acid (prepared as described in Example 1j, 0.100 g, 0.300 mmol) and 2-(3-fluoro-benzylamino)-cyclopentanecarboxylic acid ethyl ester (0.080 g, 0.300 mmol) in N,N-dimethylformamide (1.5 mL) was treated with N-methylmorpholine (63.7 mg, 0.63 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (60.4 mg, 0.315 mmol) and stirred at 25° C. for 4 h. The solvent was removed in vacuo. The crude material was redissolved in ethyl acetate (75 mL) and washed twice with 1.0 M aqueous hydrochloric acid solution (50 mL). The organic layer was then dried over sodium sulfate, filtered and concentrated in vacuo. The crude intermediate was redissolved in ethanol (5 mL) and treated with a 21% w/w solution of sodium ethoxide in ethanol (448 μL, 1.2 mmol) and stirred for 2 h at 60° C. The reaction was allowed to cool to 25° C., treated with glacial acetic acid (0.4 mL), the solvents were removed in vacuo, and the residue was purified by prep-HPLC [Column Luna 5μ C18 (2) 100 Å AXIA 50×21.2 mm, 5 micron, 30%-90% in 7 min @ 30 mL/min flow rate, 0.05% trifluoroacetic acid in acetonitrile/0.05% trifluoroacetic acid in water] to afford the desired product, cis-N-{3-[1-(3-fluoro-benzyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl]-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide (50.9 mg, 0.095 mmol, 31.7%), as a white solid. 1H NMR (400 MHz, DMSO-d6) δ: 1.46-1.62 (3H, m), 1.97-2.19 (3H, m), 3.06 (3H, s), 3.86-3.93 (1H, m), 4.46-4.55 (1H, m), 4.94 (1H, d, J=15.6 Hz), 7.07-7.12 (1H, m), 7.18-7.20 (2H, m), 7.35-7.41 (1H, m), 7.50-7.53 (1H, m), 7.58-7.60 (2H, m), 10.18 (1H, s). LC-MS (ESI) calcd for C23H23FN4O6S2 534.10, found 535.4 [M+H+].

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07582626B2
Source datasetuspto-grants-2009_09
ORD IDord-bf3ff2fc343c48749bcd19ada9b68f84
Source noteuspto-grants-2009_09